chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client developed bronchoconstriction with shortness of breath 3-4 hours after administration of vaccine. Symptoms persist intermitently(3-4 times a day) for the past 9 days. Hx. of hay fever and asthma in childhood.
Initial report received via a search of the scientific literature on 11 March 2014. The literature article provides information for two patients who experienced similar events after receiving smallpox vaccine. This case pertains to one of the two patients; information for the other patient is captured in case number 2014SA033350. Abstract: "Post-vaccinial non-viral folliculitis has been recognized in the past decade as a new adverse cutaneous reaction to smallpox vaccination. Contrary to more serious smallpox vaccine reactions, post-vaccinial non-viral folliculitis has a benign course and resolves spontaneously within approximately 7 days. We describe additional histopathologic findings associated with post-vaccinial non-viral folliculitis, which has only been described once previously. New findings include the presence of a neutrophilic or lymphohistiocytic infiltrate that is concentrated around the hair follicles. We compare our findings to the follicular nature of varicella and herpes zoster infections, generating the hypothesis of deposition of vaccinia protein within folliculosebaceous units as a potential pathophysiologic mechanism behind post-vaccinial non-viral folliculitis." A 21-year-old male, with a remote childhood history of eczema, received a left arm injection of ACAM2000 (lot number and date of vaccination not reported). Eleven days post-vaccination he presented to dermatology clinic with complaints of a rash, fatigue, malaise, flu-like symptoms, headache (treated with acetaminophen), pain at injection site, and left axilla lymphadenopathy. The rash was described as approximately 50 3-4mm pink papules on an erythematous base across the chest and upper back, some with a central pinpoint white pustule. Bacterial culture of the pustules was sterile. Skin biopsy of a papule revealed the following: a neutrophilic infiltrate within and surrounding a hair follicle with rupture of the follicular epithelium. Scattered lymphocytes were present adjacent to the follicle in the superficial dermis, the majority labeled with CD3; CD4, CD8, and TIA-1 were also noted to be present. No fungal organisms were seen, and viral cytopathic changes were not seen. The patient was determined to have post-vaccinial non-viral folliculitis. According to the authors, the event was possibly "a pustular hypersensitivity reaction". Outcome was not reported. Documents held by sender: none.
STOOL CHANGED FOR LAST WEEK SINCE ROTATEQ.  STOOLS MORE FREQUENT WITH BLOOD TINGED MUCOUS.
Following adm of 1st Pfizer vaccine, she developed double vision the next day.   This has persisted since.   She has brief periods in the morning when her vision seems normal, but then her vision blurs, is doubled, and at times is transposed (what is on the right is seen on the left).  She also has a pain in her right eye that occurs occasionally.  She denies headache and nausea.
Information has been received from a registered nurse concerning a 29 year old male with no known allergies and a history of fainting after blood draws, who on 15 September 2005, in the late afternoon, was vaccinated subcutaneously with a 0.5 ml dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot# 649675/0240R). There was no concomitant medication. About three minutes post vaccination, the patient began to making a groaning sound and his eyes rolled back into his head. It was noted that his upper body became very stiff, and he was unresponsive. The patient was assisted to the floor. After about one minute, he began to return to normal and slowly oriented to person, place and time. The patient also complained of extreme tiredness and feeling hot. The patient was taken to the emergency room and was released without intervention. The patient's blood sugar was check and found to be within normal limits. Vital signs were stable and an EKG was completed with negative results. The patient was diagnosed as having a vasovagal episode. Subsequently, the patient fully recovered. No product complaint was involved. The reporting registered nurse felt that the event was "in no way related to the vaccination since it occurred within only 3 minutes of receiving the vaccine." Additional information has been requested.
Joint pain (ankles, knee, pelvis, neck); muscle pain (calves, thighs, shoulder, neck); Pain stated 24 hours after shot, and lasted for 24 hours.
Had same numbing feeling when he got the shot; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Had same numbing feeling when he got the shot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Had same numbing feeling when he got the shot). At the time of the report, HYPOAESTHESIA (Had same numbing feeling when he got the shot) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jan-2021, Blood pressure measurement: 190/110 mmHg High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medication was reported.
MENACTRA was administerd instead of PENTACEL (DTAP, IPV, HIB). No reported adverse events or symptoms.
Patient woke up was very white/pale except for a fine red rash on both cheeks and across his nose (butterfly rash), had bilateral upper extremities tremor which affect his ability to eat with a spoon, muscle weakness, lethargic "out of it" or slow to respond to requests, low grade fever. Symptoms lasted for about 5 hours, except for the lethargy and "out of it" lasted for 1 day.
R thigh hurt f/time of vaccination to 7/20. On 7/20 stopped hurting & developed red swollen area distal to vacc site. Approx 2 inches in diameter, sl. tender. Increased in size over next 2 days, feels warm. Seen in offie today 7/22. I started antibiotics.
Pfizer on 3/3 and 3/24. Positive on 10/22
Pfizer-BioNTech COVID-19 Vaccine EUA?  Soreness at site of injection Significant muscle aches, chills Moderate fever  Minor fatigue   Symptoms increased gradually until approximately 8pm  Moderate symptoms lasted from 8pm until approximately 12am when fever broke
Extreme, extreme pain and increasing pain in upper left arm and near shoulder.  Not able or barely able to move arm. Any little movement or effort causes extreme pain. Gets worse wit time passage.
Information has been received from a pharmacist and refers to a patient of unknown age and gender. There was no information about patient's concurrent conditions, medical history or concomitant medications. On unspecified dates, the patient was vaccinated with a dose of improperly stored ZOSTAVAX lot # N016185 and expiration date of 31-JUL-2018, (route of administration and anatomical location were not reported) for prophylaxis, which were stored in the range of 15 Fahrenheit degrees to 46 Fahrenheit degrees for 23 hours. Vaccine was reconstituted with properly stored  sterile diluent (MERCK STERILE DILUENT). No previous temperature excursion was reported.  No adverse effects were reported. Digital data logger was involved. This is one of several reports from the same source.; Sender's Comments: US-009507513-1712USA013911: US-009507513-1712USA013912:
Presented to ER the day of vaccination with a swollen right arm.  Was told to apply ice to area.  Patient was then seen 8/29/03 for flu with  Medical Doctor at another Medical clinic.  No problems
Panic Attack feeling; Sore to numbness in arm; Sore to numbness in arm; hot from neck down to torso; sharp hot prickly feeling throughout the area; Redness in neck; Tightness of chest; shortness of breath; Disgust of food; loss of appetite; major fatigue; This is a spontaneous report from a contactable consumer or other non hcp. A 33-years-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Formulation: Solution for injection, Lot number was not reported) dose 1, via an unspecified route of administration on 26Feb2021 14:45 (at 33-years of age) as single dose for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing, anxiety from an unknown date and unknown if ongoing, depression from an unknown date and unknown if ongoing, survivor of cancerous ovarian cysts from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing. Concomitant medications included ibuprofen (IBUPROFEN) taken for an unspecified indication, IUD, ibuprofen, inhaler, vitamins start and stop date were not reported. The patient previously took caffeine and experienced drug hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. Patient had Known allergies: Sulfa results into violent allergy and caffeine must be kept to a minimum or none at all. It was reported that on 26Feb2021 at 09:00 pm, patient experienced Panic Attack feeling all day following the injection. Sore to numbness in arm, hot from neck down to torso, sharp hot prickly feeling throughout the area. Redness in neck Tightness of chest and shortness of breath...inhaler was needed throughout the day. Disgust of food and loss of appetite with major fatigue throughout the entire day. The outcome of the events was unknown. Therapeutic measures were taken as a result of shortness of breath (dyspnoea).  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Infection; Sick; TSA levels increased and blood work done today and this is coming back to the way that normally/; Blood pressure increased; This spontaneous case was reported by a physician and describes the occurrence of INFECTION (Infection) and ILLNESS (Sick) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product RUXOLITINIB PHOSPHATE (JAKAFI) tablet for Myelofibrosis.    Concurrent medical conditions included Myelofibrosis. Concomitant products included WARFARIN SODIUM (COUMADIN), OLMESARTAN MEDOXOMIL (BENICAR) and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.   On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and RUXOLITINIB PHOSPHATE (JAKAFI) (Oral) 10 mg twice a day. In May 2021, the patient experienced ILLNESS (Sick) (seriousness criterion hospitalization). On an unknown date, the patient experienced INFECTION (Infection) (seriousness criterion hospitalization), BLOOD THYROID STIMULATING HORMONE INCREASED (TSA levels increased and blood work done today and this is coming back to the way that normally/) and BLOOD PRESSURE INCREASED (Blood pressure increased). The patient was hospitalized for 5 days due to ILLNESS and INFECTION. At the time of the report, INFECTION (Infection), ILLNESS (Sick), BLOOD THYROID STIMULATING HORMONE INCREASED (TSA levels increased and blood work done today and this is coming back to the way that normally/) and BLOOD PRESSURE INCREASED (Blood pressure increased) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: increased (High) Increased. On an unknown date, Blood test: abnormal (abnormal) Abnormal. On an unknown date, Blood thyroid stimulating hormone: increased (High) Increased.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Concomitant medication and the underlying Myelofibrosis are potential confounders for the event "infection"; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Concomitant medication and the underlying Myelofibrosis are potential confounders for the event "infection"
Vaccine was at room temperature for 19 hours, past recommended storage. Advised patient we would contact manufacturer for recommendation.
Immediately after vaccination, pt was sitting in chair in clinic lobby, she states she felt like she was having a panic attack and that is the last thing she remembers. She fell out of chair and hit her head on the clinic floor.  Staff responded to pt lying in the lobby floor with a quarter sized  red knot on left side of forehead. Pt complained of a headache, was found to be diaphoretic and had nausea and small amount of emesis but had moderate nausea for 30 minutes after event. Vitals were obtained and WNL. EMS was called and pt agreed to be transported to ER for evaluation.
Had  2nd Covid  vaccination at 11:35 a.m in right arm on 1/25/21. Around 10:15 p.m. starting having chills. Temp was 99.0 degrees. Could not warm up. Could not sleep. Extremely restless. Was awake every hour. Drank water while awake.  Had unexplained joint pain in all fingers, both wrists, both knees and both ankles. Temp gradually went up throughout the night. Temp reached 101 degrees around 3 a.m. Took 2 Tylenol at that time.  Temp eventually went down to 100 degrees around 6 a.m.  Chills subsided. Soreness in right arm. Next morning, temp went back up to 100.9. Still restless but couldn't sleep. Took Tylenol again at 7:30 a.m. Joint pain subsided. Increased fluid intake. Temp went back up to 101 around 3 p.m. Took 2 Tylenol again. Temp went down to 99 around 5 p.m.  No more fever, chills or joint pain after that time. Next morning, 1/26/21, extremely tired but no longer had any of the above symptoms.
No adverse reaction; got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) in a 93-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse reaction). At the time of the report, EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) outcome was unknown.      For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse reaction) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD).    No concomitant medications were reported.  It was reported that, the patient received vaccine after the beyond use-by date.  No treatment medications were reported.
NO ADVERSE EVENT REPORTED. DOSE ADMINISTRATION ERROR. PATIENT GIVEN 3RD DOSE (0.5mls) WHEN THEY QUALIFIED FOR BOOSTER DOSE 0.25mls only
Patient reported right ankle swelling and pain for four days after shot. Patient stated they "had to use walker to get around" and "couldn't stand for even a bedsheet at night to touch it".  Patient did not seek medical attention and symptoms resolved on their own. Patient refused second dose of series.
Patient stated that 2 days after receiving Moderna he had severe joint pain.  Could not lift arms above shoulders, make a fist, hard to stand after sitting.  He saw doctor beginning of following week and prescribed a round of prednisone.  I spoke with patient today and said that he is feeling better and strength is returning but, still weak.  Doctor told him to delay taking his 2nd dose of Moderna for 1 month.
rash; pain; nausea; vomiting; Acute herpes zoster; This case was reported by a pharmacist via call center representative and described the occurrence of herpes zoster in a 87-year-old female patient who received Herpes zoster (Shingrix) (batch number LE55F, expiry date unknown) and (batch number 3HX44, expiry date unknown) for prophylaxis.   The patient's past medical history included shingles (was located on the left buttock and was treated with famciclovir in August 2015). Previously administered products included famciclovir (received on an unknown date) and Zostavax (received on 15th August 2013). Concomitant products included Herpes zoster (Shingrix).   On 1st October 2019, the patient received the 2nd dose of Shingrix. On an unknown date, the dose was an unknown dose. On 17th October 2019, 16 days after receiving Shingrix, 84 days after receiving Shingrix and an unknown time after starting famciclovir and Calamine, the patient experienced herpes zoster. On an unknown date, the patient experienced rash, pain, nausea and vomiting. The patient was treated with famciclovir, calamine lotion (Calamine), paracetamol (Tylenol) and prochlorperazine (Compazine Suppository). On an unknown date, the outcome of the herpes zoster, rash, pain, nausea and vomiting were unknown.   It was unknown if the reporter considered the herpes zoster, rash, pain, nausea and vomiting to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not reported but it could be 86 or 87 years. The reporter stated that patient received vaccine and had shingles on her right chest wall. The reporter consented to follow up.
Lymph node under the left armpit is swollen to about the size of a tennis ball. Pain shoots down to my elbow and then my wrist.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 22-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Vaccine lot unknown reason: Unable to locate or read the details. Other Medication in 2 weeks: No. Patient took Paxlovid (Lot number: 1919256A) from 26Sep2022 till 28Sep2022 for treatment of COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a nurse concerning a 11 year old male patient who on 20-JUL-2010 was vaccinated with a dose of VARIVAX (Merck) (lot 665967/0224Z). On 21-JUL-2010, one day post vaccination, the patient experienced redness and warmth at the injection site. The patient was treated with prednisone "Z-pak". The office followed-up with the patient on 23-JUL-2010 and he was fine. The nurse also reported that the VARIVAX (Merck) was the only vaccine received given at that particular injection site. The patient sought unspecified medical attention. Additional information has been requested.
SEIZURE LASTED 10-30 SECONDS; WENT TO ER; NO TREATMENT INITIATED.  AFTER BLINKING EYELIDS BUT RETURNED TO NORMAL ACTIVITY.
DTaP given on 8/26-06.  Redness, swelling, itching noticed only this morning (8-28-06).  Treated with KEFLEX and BENADRYL.  8-31-06 Grand mom told us all the redness, swelling, itching are completely gone.
Headache, NauseaVomiting, pain and discomfort in left arm, chills Narrative:
I woke up around 2:30 in the morning of the 18th and I was having pain that went across my shoulders. In half an hour, it was going down both arms, up my neck and in my jaw. I started having chest pains. I went to the ER and they sent me to another hospital where they gave me blood thinners. They think something affected my heart or I had a blood clot. I was discharged two days later and was given an MRI of my heart. They determined that the lining of my heart was swollen. I am now on blood pressure meds and cholesterol meds and am not allowed to spike my heart rate for the next 3-6 months. The doctors believe it was caused by the vaccine.
10:45 had chest pain, numbness in L arm, dizzy. Followed standing orders: BENADRYL 4tsp. po. given. Sent to hospital via rescue squad.
Patient experienced fatigue, chills (temperature 99.8 F), increased touch sensitivity, headache for one day. Symptoms improved without medication or medical treatment.
severe body aches, headache, fatigue, temperature 100 degrees  treated with ice packs and bed rest until 03/07/2021.  I thought these were side effects of 2nd vaccine, not1st vaccine  I signed up for and was confirmed to get  the Pfizer vaccine however only Moderma was available at date, time, and place of my appointment.   Not sure I should get the second dose of this vaccine?
t102, screamed off & on x 2 days, would only open eyes briefly, m/s stopped breathing briefly but resumed on own, pale, skin clammy;
watering nose; tearing eyes; burning eyes; red eye; A spontaneous report was received from a consumer concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events watering nose, tearing eyes, burning eyes, red eye.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 038A21A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 24 Mar 2021, the patient experienced the event(s) watering nose, tearing eyes, burning eyes, red eye.  Treatment details included Visine.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), watering nose, tearing eyes, burning eyes, red eye was unknown.
Patient called Saturday about 7 p.m. and said her right arm was sore. She was advised to ice area of vaccine. Sunday, 12-8, she called and said her arm was sore and swollen and she was going to emergency room for treatment.
14DEC98 lt arm/hand achiness, tingling, numbness, malaise, worse in AM;APAP since 10DEC;warm compresses suggested;17DEC no more numbness, sl pain w/pressure, still hot compresses as needed esp stiff & sore in morning;
H1N1 vaccine (injectable) given 12/11/09 developed hives and itching 2 days later; Patient treated with Medrol on 12/15/09 with immovement => No sign of involvement on 12/21/09.